financetom
Business
financetom
/
Business
/
BRIEF-Cedar Fair and Six Flags Announce Anticipated Closing Date of the Mergers and Six Flags' Related Special Dividend
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Cedar Fair and Six Flags Announce Anticipated Closing Date of the Mergers and Six Flags' Related Special Dividend
Jun 18, 2024 4:43 AM

June 18 (Reuters) - Cedar Fair LP ( FUN ):

* CEDAR FAIR AND SIX FLAGS ANNOUNCE ANTICIPATED CLOSING DATE

OF

THE MERGERS AND SIX FLAGS' RELATED SPECIAL DIVIDEND

* CEDAR FAIR ( FUN ) : CLOSING OF CO'S AND SIX FLAGS' PREVIOUSLY

ANNOUNCED

MERGER EXPECTED TO OCCUR ON JULY 1

* CEDAR FAIR LP ( FUN ): SIX FLAGS DECLARED A SPECIAL DIVIDEND OF

$1.53

PER SHARE OF SIX FLAGS COMMON STOCK

Source text for Eikon:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Biohaven's genetic disease drug meets main trial goal
Biohaven's genetic disease drug meets main trial goal
Oct 3, 2024
(Reuters) - Biohaven ( BHVN ) has met the main goal in a study evaluating its drug in patients with an inherited disease that mainly affects the brain, the company said on Monday. The drug troriluzole showed clinically meaningful slowing of disease progression in patients with Spinocerebellar Ataxia (SCA), the company said. The neurodegenerative disease affects about 15,000 people in...
Ventyx Biosciences Shares Up as Sanofi to Invest $27 Million
Ventyx Biosciences Shares Up as Sanofi to Invest $27 Million
Oct 3, 2024
08:25 AM EDT, 09/23/2024 (MT Newswires) -- Ventyx Biosciences ( VTYX ) shares were up 25% in recent Monday premarket activity after announcing it will receive a $27 million investment from Sanofi ( SNY ) . Sanofi ( SNY ) agreed to purchase 70,601 of the Company's Series A non-voting convertible preferred shares, each initially convertible into 100 shares, Ventyx...
Zevra Therapeutics prices genetic disorder drug at up to $106,000 per month
Zevra Therapeutics prices genetic disorder drug at up to $106,000 per month
Oct 3, 2024
Sept 23 (Reuters) - Zevra Therapeutics' ( ZVRA ) drug, Miplyffa, for treating a rare and fatal genetic disorder will have a wholesale acquisition cost ranging between $40,000 and $106,000 per month depending on dosage, the company said on a conference call on Monday. The U.S. health regulator on Friday approved the drug making it the first treatment to get...
Exchange-Traded Funds, Equity Futures Edge Higher Pre-Bell Monday Ahead of Key Inflation Data
Exchange-Traded Funds, Equity Futures Edge Higher Pre-Bell Monday Ahead of Key Inflation Data
Oct 3, 2024
08:27 AM EDT, 09/23/2024 (MT Newswires) -- The broad market exchange-traded fund SPDR S&P 500 ETF Trust ( SPY ) was up 0.1% and the actively traded Invesco QQQ Trust (QQQ) was 0.2% higher in Monday's premarket activity, ahead of a key inflation data release due later in the week. US stock futures were also edging higher, with S&P 500...
Copyright 2023-2026 - www.financetom.com All Rights Reserved